SV2004001430A - Combinacion farmaceutica ref. pc22050 - Google Patents

Combinacion farmaceutica ref. pc22050

Info

Publication number
SV2004001430A
SV2004001430A SV2002001430A SV2002001430A SV2004001430A SV 2004001430 A SV2004001430 A SV 2004001430A SV 2002001430 A SV2002001430 A SV 2002001430A SV 2002001430 A SV2002001430 A SV 2002001430A SV 2004001430 A SV2004001430 A SV 2004001430A
Authority
SV
El Salvador
Prior art keywords
pharmaceutical combination
ref
treatment
combination ref
sequential
Prior art date
Application number
SV2002001430A
Other languages
English (en)
Inventor
Michael Yeadon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SV2004001430A publication Critical patent/SV2004001430A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA COMBINACION DE UN INHIBIDOR SELECTIVO DE PDE4 COMO SE DEFINE EN LA PRESENTE MEMORIA Y UN AGONISTA DEL RECEPTOR ß2-ADRENERGICO, PARA LA ADMINISTRACION SIMULTANEA, SECUENCIAL O POR SEPARADO POR VIA INHALADA EN EL TRATAMIENTO DE UNA ENFERMEDAD OBSTRUCTIVA DE LAS VIAS RESPIRATORIAS U OTRA ENFERMEDAD INFLAMATORIA.
SV2002001430A 2001-12-07 2002-12-06 Combinacion farmaceutica ref. pc22050 SV2004001430A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0129395.0A GB0129395D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination

Publications (1)

Publication Number Publication Date
SV2004001430A true SV2004001430A (es) 2004-02-24

Family

ID=9927247

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2002001430A SV2004001430A (es) 2001-12-07 2002-12-06 Combinacion farmaceutica ref. pc22050

Country Status (33)

Country Link
US (2) US20030119862A1 (es)
EP (1) EP1455783A1 (es)
JP (1) JP2005511657A (es)
KR (1) KR20050044699A (es)
CN (1) CN1599609A (es)
AP (1) AP2004003054A0 (es)
AR (1) AR037712A1 (es)
AU (1) AU2002353255A1 (es)
BR (1) BR0214776A (es)
CA (1) CA2468676A1 (es)
CO (1) CO5590899A2 (es)
EA (1) EA200400640A1 (es)
EC (1) ECSP045142A (es)
GB (1) GB0129395D0 (es)
HN (1) HN2002000356A (es)
HR (1) HRP20040515A2 (es)
HU (1) HUP0402546A3 (es)
IL (1) IL162098A0 (es)
IS (1) IS7277A (es)
MA (1) MA27152A1 (es)
MX (1) MXPA04004930A (es)
NO (1) NO20042870L (es)
NZ (1) NZ533030A (es)
OA (1) OA12736A (es)
PA (1) PA8560601A1 (es)
PE (1) PE20031066A1 (es)
PL (1) PL370770A1 (es)
SV (1) SV2004001430A (es)
TN (1) TNSN04102A1 (es)
TW (1) TWI242433B (es)
UY (1) UY27564A1 (es)
WO (1) WO2003047578A1 (es)
ZA (1) ZA200403905B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
DE10360954B3 (de) * 2003-12-23 2005-08-18 Esparma Gmbh Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen
WO2012098495A1 (en) * 2011-01-19 2012-07-26 Glenmark Pharmaceuticals Sa Pharmaceutical composition that includes revamilast and a beta-2 agonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0837860T3 (da) * 1995-06-06 2002-05-27 Pfizer Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner
BR9913152A (pt) * 1998-08-26 2001-05-15 Smithkline Beecham Corp Terapias para tratamento de doenças pulmonares
KR100701904B1 (ko) * 1999-08-21 2007-04-02 알타나 파마 아게 Ｐｄｅ 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합

Also Published As

Publication number Publication date
OA12736A (en) 2006-06-29
GB0129395D0 (en) 2002-01-30
HRP20040515A2 (en) 2004-10-31
ZA200403905B (en) 2005-06-22
IL162098A0 (en) 2005-11-20
CO5590899A2 (es) 2005-12-30
HN2002000356A (es) 2003-02-21
WO2003047578A1 (en) 2003-06-12
TWI242433B (en) 2005-11-01
CN1599609A (zh) 2005-03-23
AR037712A1 (es) 2004-12-01
EA200400640A1 (ru) 2004-12-30
EP1455783A1 (en) 2004-09-15
TNSN04102A1 (fr) 2006-06-01
CA2468676A1 (en) 2003-06-12
NZ533030A (en) 2007-03-30
UY27564A1 (es) 2003-07-31
PA8560601A1 (es) 2005-02-04
AU2002353255A1 (en) 2003-06-17
HUP0402546A2 (hu) 2005-04-28
US20040167153A1 (en) 2004-08-26
KR20050044699A (ko) 2005-05-12
ECSP045142A (es) 2004-07-23
PL370770A1 (en) 2005-05-30
MA27152A1 (fr) 2005-01-03
BR0214776A (pt) 2004-11-09
JP2005511657A (ja) 2005-04-28
TW200300678A (en) 2003-06-16
AP2004003054A0 (en) 2004-06-30
IS7277A (is) 2004-05-21
HUP0402546A3 (en) 2008-04-28
PE20031066A1 (es) 2003-12-24
US20030119862A1 (en) 2003-06-26
MXPA04004930A (es) 2005-04-08
NO20042870L (no) 2004-07-06

Similar Documents

Publication Publication Date Title
PA8546101A1 (es) Un antagonista de a2a en combinacion con un agente anticolinergico para el tratamiento de enfermedades obstructivas de las vias aereas
ATE413162T1 (de) Pharmazeutische zusammensetzungen zur sicheren verabreichung von bei der behandlung von drogenabhängigkeit verwendeten arzneimitteln
CL2008003595A1 (es) Compuestos heterociclicos nitrogenados, antagonistas del receptor de taquiquinina; agente farmaceutico que comprende el compuesto; y uso en la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior, una enfermedad gastrointestinal o una enfermedad del sistema nervioso central.
HN2004000319A (es) "{ 1,8}naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia"
EA200800618A1 (ru) Комбинация снотворного агента длительного действия и снотворного агента короткого действия
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
ATE355065T1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
NO20052496D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
CY1114139T1 (el) Πλακιδιο βουπρενορφινης για τη θεραπεια υποκαταστασης ναρκωτικων
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
MXPA03008955A (es) Agente terapeutico para enfermedades de tipo artritides cronicas o enfermedades relacionadas con la ninez.
WO2006124681A3 (en) Oral drug delivery system and methods of use thereof
DE60318237D1 (de) Pharmazeutische zusammensetzungen enthaltend flavonoide und menthol
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
PA8546001A1 (es) Un inhibidor de pde4 y un agente anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias
CR9142A (es) Medicamento para administracion higienica en el oido
AR049876A1 (es) Composiciones farmaceuticas para tratar enfermedades de la piel que comprenden una combinacion de epinastina y uno o mas minerales adicionales o uno o mas farmacos brutos
SE0302488D0 (sv) New combination
EA201101119A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
EA200600953A1 (ru) Дозированные формы торсемида пролонгированного высвобождения
SV2004001430A (es) Combinacion farmaceutica ref. pc22050
SV2004001426A (es) Combinacion farmaceutica ref.pcs22049
PA8560401A1 (es) Combinacion farmaceutica
ATE481971T1 (de) Formulierung von 3-amino-8-(1-piperazinyl)-2h- 1benzopyran-2-on mit verzögerter freisetzung
ATE389402T1 (de) Sedierende nicht-benzodiazepin-formulierungen

Legal Events

Date Code Title Description
FD Lapse